Pharmadrug Inc. (PHRX.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.45 Million CAD | -87.95% |
| 2022 | 12.11 Million CAD | -37.95% |
| 2021 | 19.52 Million CAD | 42.6% |
| 2020 | 13.68 Million CAD | 31.89% |
| 2019 | 10.37 Million CAD | 876.97% |
| 2018 | 1.06 Million CAD | 961.16% |
| 2017 | 100.1 Thousand CAD | -12.6% |
| 2016 | 114.54 Thousand CAD | -98.54% |
| 2015 | 7.86 Million CAD | -8.52% |
| 2014 | 8.59 Million CAD | 1026.0% |
| 2013 | 763.74 Thousand CAD | -37.04% |
| 2012 | 1.21 Million CAD | 304.33% |
| 2011 | 300 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 843.37 Thousand CAD | -16.95% |
| 2024 Q1 | 1.01 Million CAD | -30.43% |
| 2023 Q3 | 11.93 Million CAD | 0.47% |
| 2023 Q2 | 11.88 Million CAD | -0.86% |
| 2023 Q4 | 1.45 Million CAD | -87.77% |
| 2023 FY | 1.45 Million CAD | -87.95% |
| 2023 Q1 | 11.98 Million CAD | -1.05% |
| 2022 Q1 | 17.96 Million CAD | -7.96% |
| 2022 Q3 | 12.6 Million CAD | -6.13% |
| 2022 Q4 | 12.11 Million CAD | -3.9% |
| 2022 FY | 12.11 Million CAD | -37.95% |
| 2022 Q2 | 13.42 Million CAD | -25.27% |
| 2021 Q2 | 21.94 Million CAD | -5.18% |
| 2021 Q4 | 19.52 Million CAD | -4.22% |
| 2021 FY | 19.52 Million CAD | 42.6% |
| 2021 Q1 | 23.14 Million CAD | 69.11% |
| 2021 Q3 | 20.38 Million CAD | -7.15% |
| 2020 Q1 | 10.17 Million CAD | -2.0% |
| 2020 Q2 | 16.13 Million CAD | 58.62% |
| 2020 Q3 | 15.12 Million CAD | -6.24% |
| 2020 Q4 | 13.68 Million CAD | -9.5% |
| 2020 FY | 13.68 Million CAD | 31.89% |
| 2019 Q2 | 13 Million CAD | 178.37% |
| 2019 Q4 | 10.37 Million CAD | -5.32% |
| 2019 FY | 10.37 Million CAD | 876.97% |
| 2019 Q1 | 4.67 Million CAD | 339.84% |
| 2019 Q3 | 10.96 Million CAD | -15.73% |
| 2018 FY | 1.06 Million CAD | 961.16% |
| 2018 Q4 | 1.06 Million CAD | 4.38% |
| 2018 Q3 | 1.01 Million CAD | 1802.71% |
| 2018 Q2 | 53.49 Thousand CAD | -46.6% |
| 2018 Q1 | 100.17 Thousand CAD | -2.51% |
| 2017 Q1 | 123.72 Thousand CAD | 14.61% |
| 2017 Q2 | 121.23 Thousand CAD | -2.01% |
| 2017 Q3 | 100.1 Thousand CAD | -17.43% |
| 2017 Q4 | 102.74 Thousand CAD | 2.63% |
| 2017 FY | 100.1 Thousand CAD | -12.6% |
| 2016 Q1 | 7.82 Million CAD | -0.59% |
| 2016 FY | 114.54 Thousand CAD | -98.54% |
| 2016 Q3 | 114.54 Thousand CAD | 8.07% |
| 2016 Q2 | 105.99 Thousand CAD | -98.65% |
| 2016 Q4 | 107.94 Thousand CAD | -5.76% |
| 2015 Q1 | 7.91 Million CAD | -4.42% |
| 2015 Q4 | 7.87 Million CAD | 0.09% |
| 2015 FY | 7.86 Million CAD | -8.52% |
| 2015 Q2 | 7.81 Million CAD | -1.24% |
| 2015 Q3 | 7.86 Million CAD | 0.61% |
| 2014 Q1 | 7.59 Million CAD | -3.94% |
| 2014 FY | 8.59 Million CAD | 1026.0% |
| 2014 Q2 | 7.6 Million CAD | 0.04% |
| 2014 Q3 | 8.59 Million CAD | 13.15% |
| 2014 Q4 | 8.28 Million CAD | -3.68% |
| 2013 FY | 763.74 Thousand CAD | -37.04% |
| 2013 Q2 | 1.07 Million CAD | -4.93% |
| 2013 Q1 | 1.13 Million CAD | -3.3% |
| 2013 Q3 | 763.74 Thousand CAD | -29.28% |
| 2013 Q4 | 7.9 Million CAD | 935.51% |
| 2012 Q1 | 1.25 Million CAD | 25.89% |
| 2012 Q2 | 1.22 Million CAD | -2.49% |
| 2012 Q3 | 1.21 Million CAD | -0.72% |
| 2012 Q4 | 1.17 Million CAD | -3.17% |
| 2012 FY | 1.21 Million CAD | 304.33% |
| 2011 Q4 | 995.28 Thousand CAD | 0.0% |
| 2011 FY | 300 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aion Therapeutic Inc. | 210.67 Thousand CAD | -592.871% |
| Ayurcann Holdings Corp. | 14.85 Million CAD | 90.173% |
| Blueberries Medical Corp. | 2.41 Million CAD | 39.599% |
| The BC Bud Corporation | 632.06 Thousand CAD | -130.939% |
| BioNxt Solutions Inc. | 1.26 Million CAD | -15.157% |
| CordovaCann Corp. | 10.26 Million CAD | 85.778% |
| Christina Lake Cannabis Corp. | 15.96 Million CAD | 90.856% |
| Captor Capital Corp. | 33.85 Million CAD | 95.688% |
| City View Green Holdings Inc. | 3846.00 CAD | -37853.354% |
| 1CM Inc. | 34.01 Million CAD | 95.709% |
| Global Hemp Group Inc. | 42.76 Thousand CAD | -3313.592% |
| Greenway Greenhouse Cannabis Corporation | 33.08 Million CAD | 95.589% |
| IM Cannabis Corp. | 48.81 Million CAD | 97.01% |
| Lobe Sciences Ltd. | 2.29 Million CAD | 36.521% |
| Maple Leaf Green World Inc. | 168.27 Thousand CAD | -767.451% |
| Mountain Valley MD Holdings Inc. | 8.96 Million CAD | 83.72% |
| Nextleaf Solutions Ltd. | 8.53 Million CAD | 82.902% |
| Ovation Science Inc. | 76.88 Thousand CAD | -1798.457% |
| Captiva Verde Wellness Corp. | 9.1 Million CAD | 83.964% |
| RAMM Pharma Corp. | 32.3 Million CAD | 95.481% |
| RIV Capital Inc. | 1.74 Million CAD | 16.137% |
| Revive Therapeutics Ltd. | 10.63 Million CAD | 86.276% |
| Red White & Bloom Brands Inc. | 234.25 Million CAD | 99.377% |
| SLANG Worldwide Inc. | 33.2 Million CAD | 95.604% |
| 1933 Industries Inc. | 18.01 Million CAD | 91.9% |
| Red Light Holland Corp. | 24.08 Million CAD | 93.939% |
| Top Strike Resources Corp. | 11.73 Million CAD | 87.561% |
| Xebra Brands Ltd. | 379.36 Thousand CAD | -284.768% |
| Adastra Holdings Ltd. | 32.34 Million CAD | 95.487% |